The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection

Acetylsalicylic acid (aspirin) is commonly used for primary and secondary prevention of cardiovascular diseases. Aspirin use is associated with better outcomes among COVID‐19 positive patients. We hypothesized that the aspirin use for primary cardiovascular disease prevention might have a protective...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:FEBS J
Hlavní autoři: Merzon, Eugene, Green, Ilan, Vinker, Shlomo, Golan‐Cohen, Avivit, Gorohovski, Alessandro, Avramovich, Eva, Frenkel‐Morgenstern, Milana, Magen, Eli
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2021
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013755/
https://ncbi.nlm.nih.gov/pubmed/33621437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/febs.15784
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky